Legend Biotech Corporation Appoints Ingrid Zhang as Chief Executive Officer

AI-generated NewsSnap summary based on source reporting.
Published: 2026-09-15
Category: business
Source: MarketScreener / Stock Titan (referencing 6-K filing)

Legend Biotech Corporation announced that its Board of Directors has appointed Ingrid Zhang as the new Chief Executive Officer, effective September 15, 2026. Zhang succeeds Alan Bash, who served as interim CEO since July 2026 and will resume his role as President, CARVYKTI. Zhang brings extensive global biopharmaceutical experience from her previous role as Chief Commercial Officer for Novartis International.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai